Arecor Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

AIM:AREC Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
19 May 25	BuyUK£14,913	Andrew John Richards	Individual	31,750	UK£0.47
19 May 25	BuyUK£4,700	Jan Jezek	Individual	10,000	UK£0.47
19 May 25	BuyUK£9,900	Sarah Howell	Individual	21,077	UK£0.47
13 May 25	BuyUK£14,437	Andrew John Richards	Individual	35,000	UK£0.41

Insider Trading Volume

Insider Buying: AREC insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AREC?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	82,800	0.219%
Public Companies	2,973,426	7.88%
Individual Insiders	3,611,977	9.57%
General Public	5,287,543	14%
VC/PE Firms	7,120,337	18.9%
Institutions	18,680,518	49.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.3%.

Top Shareholders

Top 25 shareholders own 80.69% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.7%	Business Growth Fund Limited	5,158,079	UK£2.2m	0%	0.58%
8.12%	JP Morgan Asset Management	3,064,496	UK£1.3m	9.68%	no data
7.76%	Unilever PLC	2,929,926	UK£1.3m	0%	no data
5.2%	Calculus Capital Limited	1,962,258	UK£853.6k	-18.4%	24.52%
4.61%	Chelverton Asset Management Limited	1,740,000	UK£756.9k	5.45%	0.08%
4.36%	The Wood Family Trust, Endowment Arm	1,646,756	UK£716.3k	0%	100.0%
4.21%	Oxford Technology Management Limited	1,587,776	UK£690.7k	0%	100.0%
4.15%	Stewart Newton	1,565,408	UK£681.0k	0%	no data
3.18%	Unicorn Asset Management Ltd.	1,198,828	UK£521.5k	0%	0.09%
2.94%	Platinum Investment Management Limited	1,111,111	UK£483.3k	0%	0.02%
2.4%	Sarah Howell	905,481	UK£393.9k	2.38%	no data
2.19%	Maven Capital Partners UK LLP	827,227	UK£359.8k	-2.71%	0.12%
2.13%	Albion Capital Group LLP	804,768	UK£350.1k	-27.7%	2.65%
1.99%	Foresight Group LLP	752,816	UK£327.5k	-51%	0.05%
1.72%	Rathbones Investment Management Limited	648,942	UK£282.3k	197%	no data
1.7%	Canaccord Genuity Asset Management Limited	640,034	UK£278.4k	3.71%	0.01%
1.34%	Downing LLP	506,070	UK£220.1k	154%	0.09%
1.34%	Hargreaves Lansdown Asset Management Ltd.	505,528	UK£219.9k	20%	no data
1.34%	Mole Valley Asset Management Ltd	505,089	UK£219.7k	-3.43%	0.8%
1.26%	Seneca Partners Limited	476,924	UK£207.5k	21%	4.06%
1.16%	Larpent Newton Holdings Limited	436,993	UK£190.1k	0%	33.15%
1.11%	Jan Jezek	417,808	UK£181.7k	2.45%	no data
1.03%	M. D. Barnard & Co. Ltd., Asset Management Arm	389,897	UK£169.6k	0%	0.11%
0.96%	Aberdeen Group Plc	364,089	UK£158.4k	22.6%	no data
0.84%	Andrew John Richards	318,361	UK£138.5k	26.5%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/06/01 08:50
End of Day Share Price	2025/05/30 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Arecor Therapeutics plc is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Julie Simmonds	Panmure Liberum
Julie Simmonds	Panmure Liberum Historic (Panmure Gordon)
Lala Gregorek	Trinity Delta Research Limited